Webinars

eThalED Webinar Series: Heart Disease in Thalassaemia
NOVITÀ

eThalED Webinar Series: Heart Disease in Thalassaemia

Last -but not least- in our eThalED Webinar Series for Medical Specialists comes ‘Heart Disease in Thalassaemia’, one the major causes of morbidity and mortality among patients with this severe…
eThalED Webinar Series: Iron Monitoring in Thalassaemia
Education

eThalED Webinar Series: Iron Monitoring in Thalassaemia

TIF´s 5th consecutive webinar for Medical Specialists and Healthcare Professionals was conducted on 7 September 2020 and revolved around the topic of ”Iron Monitoring in Thalassaemia”. Dr Paul Telfer, Consultant…
eThalED Webinar Series: Blood Transfusion in Thalassaemia
Education

eThalED Webinar Series: Blood Transfusion in Thalassaemia

TIF´s 4th Webinar for Medical Specialists and Healthcare Professionals, organised as part of our eThalED Course, was successfully held on Monday, 31 August 2020. Prof. Constantina Politis, Associate Professor of…
eThalED Webinar Series: Liver Disease & Thalassaemia
Education

eThalED Webinar Series: Liver Disease & Thalassaemia

TIF’s 3rd webinar for Medical Specialists on ”Liver Disease & Thalassaemia”, organised in the context of our eThalED Course. Prof. Geoffrey Dusheiko, Emeritus Professor of Medicine & Consultant Hepatologist at…
Advances in the Care & Cure of Thalassaemia: New Hopes & Challenges
NOVITÀ

Advances in the Care & Cure of Thalassaemia: New Hopes & Challenges

TIF, in collaboration with Thalassemics India and Thalassemia Patients Advovacy Group – India, conducted on June 12, 2020 a Webinar on the novel treatments emerging for thalassaemia and the hopes…
COVID-19 & Haemoglobin Disorders: A TIF Webinar with Patients from America
NOVITÀ

COVID-19 & Haemoglobin Disorders: A TIF Webinar with Patients from America

On June 1st, TIF representatives, Dr Androulla Eleftheriou and Dr Michael Angastiniotis and Mr Loris Brunetta, Board Member, had a fruitful discussion with patient advocates from the AMRO region about…
COVID-19 & Haemoglobin Disorders: The Impact of Coronavirus on Sickle Cell Disease Patients
NOVITÀ

COVID-19 & Haemoglobin Disorders: The Impact of Coronavirus on Sickle Cell Disease Patients

An Expert Panel of Six Medical Professionals from various countries, such as India, the UK, Italy and Saudi Arabia, shared their experiences with TIF on the impact of the COVID-19…
eThalED Webinar Series: Access to New Therapies – Reblozyl
Education

eThalED Webinar Series: Access to New Therapies – Reblozyl

The 1st webinar for Medical Specialists organised in the context of TIF’s eThalED online course is here. Dr Antonio Piga, Professor of Paediatrics & Dean of the Medicine School at…
TIF ITD2020 Webinar: The Patients’ Perspective on the Accessibility & Affordability of Novel Therapies for Thalassaemia
NOVITÀ

TIF ITD2020 Webinar: The Patients’ Perspective on the Accessibility & Affordability of Novel Therapies for Thalassaemia

9 patients with thalassaemia, members of TIF’s Patient Advocacy Group for Thalassaemia and Sickle Cell Disease (T-PAG), are discussing with the Thalassaemia International Federation the accessibility and affordability of the…
Back to top button